EA201201219A1 - PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) - Google Patents
PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS)Info
- Publication number
- EA201201219A1 EA201201219A1 EA201201219A EA201201219A EA201201219A1 EA 201201219 A1 EA201201219 A1 EA 201201219A1 EA 201201219 A EA201201219 A EA 201201219A EA 201201219 A EA201201219 A EA 201201219A EA 201201219 A1 EA201201219 A1 EA 201201219A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- metabolic
- retinoprotective
- options
- path
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к области медицины, а именно офтальмологии. Задачей настоящего изобретения является создание эффективного фармацевтического состава, обладающего метаболическим, противокатарактным, ретинопротекторным действием за счет того, что фармацевтический состав содержит таурин и дополнительно содержит минеральные вещества, а также изотопыN. При реализации заявленных фармацевтических составов на практике будет обеспечено увеличение лечебного эффекта и скорости наступления лечебного эффекта без увеличения концентрации таурина, а также повышение стабильности фармацевтического состава с таурином в течение срока годности.The invention relates to the field of medicine, namely, ophthalmology. The present invention is the creation of an effective pharmaceutical composition with metabolic, anti-cataract, retinoprotective effect due to the fact that the pharmaceutical composition contains taurine and additionally contains minerals and isotopesN. When implementing the claimed pharmaceutical formulations in practice, there will be an increase in the therapeutic effect and speed of the onset of the therapeutic effect without an increase in the concentration of taurine, as well as an increase in the stability of the pharmaceutical composition with taurine during the shelf life.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201201219A EA020389B1 (en) | 2012-10-01 | 2012-10-01 | Pharmaceutical composition comprising sodium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201201219A EA020389B1 (en) | 2012-10-01 | 2012-10-01 | Pharmaceutical composition comprising sodium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants) |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201201219A1 true EA201201219A1 (en) | 2014-04-30 |
EA020389B1 EA020389B1 (en) | 2014-10-30 |
Family
ID=50516412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201201219A EA020389B1 (en) | 2012-10-01 | 2012-10-01 | Pharmaceutical composition comprising sodium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants) |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA020389B1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294206B1 (en) * | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
PA8591801A1 (en) * | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | BENZAMID INHIBITORS OF THE P2X7 RECEIVER. |
RU2414218C1 (en) * | 2009-12-11 | 2011-03-20 | Закрытое акционерное общество "Институт фармацевтических технологий" | Eye drops for treatment of dystrophic diseases and traumas of eyes |
-
2012
- 2012-10-01 EA EA201201219A patent/EA020389B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA020389B1 (en) | 2014-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201800199A1 (en) | APPLICATION OF AKKERMANSIA MUCINIPHILA FOR THE TREATMENT OF METABOLIC DISORDERS, INCREASE ENERGY CONSUMPTION AND WEIGHT REDUCTION, COMPOSITIONS, MEDICINE | |
EA201590667A1 (en) | ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES | |
EA201691032A1 (en) | IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS | |
EA201201658A1 (en) | DERIVATIVES OF PIPERIDINE AND THEIR APPLICATION FOR THE TREATMENT OF METABOLIC DISORDERS | |
EA201491500A1 (en) | FIBROZA TREATMENT METHODS | |
EA201690005A1 (en) | COMPOSITION WITH MODIFIED EXTRUSION KINETICS | |
EA201490045A1 (en) | DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA | |
EA201200858A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201219A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201213A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201217A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201220A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201216A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201215A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201212A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201214A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201201218A1 (en) | PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS) | |
EA201300370A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300373A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300392A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300393A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201200469A1 (en) | SOLID MEDICINE FORM WITH A FUNNY RELIEF, LOCAL ENVIRONMENT AND ANTI-INFLAMMATORY ACTION (OPTIONS) | |
EA201300371A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300378A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) | |
EA201300394A1 (en) | ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |